Whitehawk Therapeutics, Inc.
WHWK
DELAYED 1 MONTH

10 insider filings · Latest: May 14, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 2, 2026Mar 10 11:36 PMDavid James LennonDirector, CHIEF EXECUTIVE OFFICER
Sale
5,100$3.31$16.9K44,579(D)

View →

Mar 2, 2026Mar 10 11:36 PMScott M. GiacobelloCHIEF FINANCIAL OFFICER
Sale
2,594$3.31$8.6K28,100(D)

View →

Mar 2, 2026Mar 10 11:35 PMBryan BallChief Technical Operations Officer and SVP, Manufacturing Operations
Sale
1,834$3.31$6.1K206,019(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 12, 2026Jul 30 8:04 PMAnupam DalalDirector
Grant/Award
38,040$4.1638,040(D)

View →

May 14, 2026May 18 8:02 PMCaley CasteleinDirector
Grant/Award
2,072,756$0.00012,072,756(I)

View →

May 12, 2026May 14 11:40 PMAvoro Capital Advisors LLCDirector, 10% Owner, Other
Grant/Award
6,377,714$0.000114,710,714(I)

View →

Mar 1, 2026Mar 10 11:36 PMDavid James LennonDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
16,250—32,500(D)

View →

Mar 1, 2026Mar 10 11:36 PMScott M. GiacobelloCHIEF FINANCIAL OFFICER
Option Exercise
6,750—13,500(D)

View →

Mar 1, 2026Mar 10 11:35 PMBryan BallChief Technical Operations Officer and SVP, Manufacturing Operations
Option Exercise
5,000—10,000(D)

View →